戻る Agenda
Wrap-Up and Closing Remarks
Session Chair(s)
Inas Chehimi
Executive Director - Regulatory & Policy Head - MEA
Novartis Pharma Services AG, United Arab Emirates
Wrap-Up and Closing Remarks
Speaker(s)
Peter J. Pitts
Center for Medicine in the Public Interest (CMPI), United States
President
Hadir Rostom
Pharmaceutical Affairs Central Administration (CAPA), Ministry of Health, Egypt, Egypt
Head, Egyptian Pharmaceutical Vigilance Center (EPVC)
Thomas Bols, MA
PTC Therapeutics, Inc., Switzerland
Head of Government affairs and Patient Advocacy, EMEA & APAC